Jude Fitzgibbon - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jude Fitzgibbon

Showing results (81-90 of 87) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 87 results.

Leukemia|August 26, 2024

Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturationVilma Dembitz, Hannah Lawson, Richard Burt, et al.

JCI Insight|December 8, 2022

Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemiaFriedrich Stölzel, Sarah E Fordham, Devi Nandana, et al.

Blood|September 28, 2016

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphomaLarry Mansouri, Daniel Noerenberg, Emma Young, et al.

Nature Communications|February 27, 2020

The complex genetic landscape of familial MDS and AML reveals pathogenic germline variantsAna Rio-Machin, Tom Vulliamy, Nele Hug, et al.

Nature Communications|October 30, 2021

Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.

Blood|August 24, 2022

Genomic profiling for clinical decision making in lymphoid neoplasmsLaurence de Leval, Ash A Alizadeh, P Leif Bergsagel, et al.

Blood|January 29, 2026

Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemiaDiyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham, et al.

Pageof 9

Search research articles

Showing results (81-90 of 87) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 87 results.

Leukemia|August 26, 2024

Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturationVilma Dembitz, Hannah Lawson, Richard Burt, et al.

JCI Insight|December 8, 2022

Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemiaFriedrich Stölzel, Sarah E Fordham, Devi Nandana, et al.

Blood|September 28, 2016

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphomaLarry Mansouri, Daniel Noerenberg, Emma Young, et al.

Nature Communications|February 27, 2020

The complex genetic landscape of familial MDS and AML reveals pathogenic germline variantsAna Rio-Machin, Tom Vulliamy, Nele Hug, et al.

Nature Communications|October 30, 2021

Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.

Blood|August 24, 2022

Genomic profiling for clinical decision making in lymphoid neoplasmsLaurence de Leval, Ash A Alizadeh, P Leif Bergsagel, et al.

Blood|January 29, 2026

Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemiaDiyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham, et al.

Pageof 9